# IRBESARTAN AND HYDROCHLOROTHIAZIDE
> **ANDA207896** · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2016-10-14
## Drug
- **FDA Application Number:** ANDA207896
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IRBESARTAN AND HYDROCHLOROTHIAZIDE
- **Generic name:** IRBESARTAN AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; IRBESARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HISUN PHARM HANGZHOU
- **Manufacturer:** Hisun Pharmaceuticals USA Inc.
- **First approval:** 2016-10-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207896)
---
*MORVS · CC0 1.0*